These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 17898097

  • 1. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
    Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F, Vaccine Safety Datalink Team.
    N Engl J Med; 2007 Sep 27; 357(13):1281-92. PubMed ID: 17898097
    [Abstract] [Full Text] [Related]

  • 2. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
    Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, Marcy M, Robertson A, Eriksen E, Lewis E, Bernal P, Shay D, Davis RL, DeStefano F.
    Pediatrics; 2010 Oct 27; 126(4):656-64. PubMed ID: 20837594
    [Abstract] [Full Text] [Related]

  • 3. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
    Tozzi AE, Bisiacchi P, Tarantino V, De Mei B, D'Elia L, Chiarotti F, Salmaso S.
    Pediatrics; 2009 Feb 27; 123(2):475-82. PubMed ID: 19171612
    [Abstract] [Full Text] [Related]

  • 4. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
    Heron J, Golding J, ALSPAC Study Team.
    Pediatrics; 2004 Sep 27; 114(3):577-83. PubMed ID: 15342824
    [Abstract] [Full Text] [Related]

  • 5. Early thimerosal exposure and neuropsychological outcomes.
    Bernard S.
    N Engl J Med; 2008 Jan 03; 358(1):93; author reply 94. PubMed ID: 18172184
    [No Abstract] [Full Text] [Related]

  • 6. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
    Young HA, Geier DA, Geier MR.
    J Neurol Sci; 2008 Aug 15; 271(1-2):110-8. PubMed ID: 18482737
    [Abstract] [Full Text] [Related]

  • 7. Early thimerosal exposure and neuropsychological outcomes.
    Rooney JP.
    N Engl J Med; 2008 Jan 03; 358(1):93-4; author reply 94. PubMed ID: 18175387
    [No Abstract] [Full Text] [Related]

  • 8. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases.
    Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT, Vaccine Safety Datalink Team.
    Pediatrics; 2003 Nov 03; 112(5):1039-48. PubMed ID: 14595043
    [Abstract] [Full Text] [Related]

  • 9. Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants.
    Marques RC, Dórea JG, Manzatto AG, Bastos WR, Bernardi JV, Malm O.
    Acta Paediatr; 2007 Jun 03; 96(6):864-8. PubMed ID: 17465985
    [Abstract] [Full Text] [Related]

  • 10. Thimerosal exposure in early life and neuropsychological outcomes 7-10 years later.
    Barile JP, Kuperminc GP, Weintraub ES, Mink JW, Thompson WW.
    J Pediatr Psychol; 2012 Jun 03; 37(1):106-18. PubMed ID: 21785120
    [Abstract] [Full Text] [Related]

  • 11. Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of life.
    Mrozek-Budzyn D, Majewska R, Kieltyka A, Augustyniak M.
    Neurotoxicol Teratol; 2012 Jun 03; 34(6):592-7. PubMed ID: 23069197
    [Abstract] [Full Text] [Related]

  • 12. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
    Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B.
    Pediatrics; 2004 Sep 03; 114(3):584-91. PubMed ID: 15342825
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
    Parker SK, Schwartz B, Todd J, Pickering LK.
    Pediatrics; 2004 Sep 03; 114(3):793-804. PubMed ID: 15342856
    [Abstract] [Full Text] [Related]

  • 15. Continuing increases in autism reported to California's developmental services system: mercury in retrograde.
    Schechter R, Grether JK.
    Arch Gen Psychiatry; 2008 Jan 03; 65(1):19-24. PubMed ID: 18180424
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Lack of association between thimerosal-containing vaccines and autism].
    Mrozek-Budzyn D, Majewska R, Kiełtyka A, Augustyniak M.
    Przegl Epidemiol; 2011 Jan 03; 65(3):491-5. PubMed ID: 22184954
    [Abstract] [Full Text] [Related]

  • 18. Regression of language and non-language skills in pervasive developmental disorders.
    Meilleur AA, Fombonne E.
    J Intellect Disabil Res; 2009 Feb 03; 53(2):115-24. PubMed ID: 19054269
    [Abstract] [Full Text] [Related]

  • 19. Changes in children hair-Hg concentrations during the first 5 years: maternal, environmental and iatrogenic modifying factors.
    Marques RC, Dórea JG, Bastos WR, Malm O.
    Regul Toxicol Pharmacol; 2007 Oct 03; 49(1):17-24. PubMed ID: 17566620
    [Abstract] [Full Text] [Related]

  • 20. Prenatal and postnatal mercury exposure, breastfeeding and neurodevelopment during the first 5 years.
    Marques RC, Dórea JG, Bernardi JV, Bastos WR, Malm O.
    Cogn Behav Neurol; 2009 Jun 03; 22(2):134-41. PubMed ID: 19506431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.